Joe S Mendez (Joe Mendez)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 6

Top Topics

Peritoneal Dialysis

Diffuse Large B Cell Lymphoma

Radiation Therapy

Top Venues

Journal of neuro-oncology

Neuro-oncology practice

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa M Arnold, Yoji Hoshina, Hyejung Lee, Howard Colman, Joe S Mendez
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors. Journal of neuro-oncology 167 (1) (2024)
Lisa M Arnold, Yoji Hoshina, Hyejung Lee, Howard Colman, Joe S Mendez
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors. Journal of neuro-oncology (2024)
Lisa M Arnold, Yoji Hoshina, Hyejung Lee, Howard Colman, Joe S Mendez
Effect of Pneumocystis jirovecii pneumonia prophylaxis on hematologic toxicity in patients receiving chemoradiation for primary brain tumors. Journal of neuro-oncology 167 (1) (2024)
Emma R Earl, Howard Colman, Joe S Mendez, Randy L Jensen, Michael J Karsy
An evaluation of biobanking and therapeutic clinical trial representation among adult glioma patients from rural and urban Utah. Neuro-oncology practice 10 (5) (2023)
Ekin Guney, Calixto-Hope G Lucas, Zhongxia Qi, Jingwei Yu, Ruth Zhang, Robert S Ohgami, James L Rubenstein, Daniel R Boué, Kristian Schafernak, Gerald B Wertheim, Jeffrey R Millman, Lisa Giulino-Roth, Andishe Attarbaschi, Matthew J Barth, Shalin Kothari, Oussama Abla, Adam L Cohen, Joe S Mendez, Andrew Bollen, Arie Perry, Tarik Tihan, Melike Pekmezci, David A Solomon, Kwun Wah Wen
A genetically distinct pediatric subtype of primary CNS large B-cell lymphoma is associated with favorable clinical outcome. Blood advances 6 (10) (2022)
Savannah Gelhard, Amiee Maxwell, Howard Colman, Adam L Cohen, Joe S Mendez
Consolidation regimens in primary central nervous system lymphoma: a single-center retrospective cohort evaluating survival outcomes and cost-benefit analysis. Journal of neuro-oncology 159 (2) (2022)